Clinical Trials | August 04, 2022
Merck and Eisai provide update on Phase 3 LEAP-002 trial evaluating KEYTRUDA
The safety profile of KEYTRUDA plus LENVIMA was consistent with previously reported data on the combination.
The safety profile of KEYTRUDA plus LENVIMA was consistent with previously reported data on the combination.
Strides is the first Indian company to get approval for the product.
The product will be manufactured at Lupin's facility in Nagpur, India.
Bisoprolol Fumarate Tablets are used to treat high blood pressure.
George Svokos joins Avet after serving as a strategic business advisor to numerous global healthcare companies
The FDA's Orphan Drug Designation is granted to investigational therapies addressing rare medical diseases or conditions that affect fewer than 200,000 people
Company provides anticipated impact to second quarter 2022 financial results due to recently completed business development transactions
The settlement and dismissal resolves all claims between the parties
The over-the-counter market has long been an important segment of Glenmark’s portfolio around the world
Most recently, she served as chief human resources officer at Vyripharm Enterprises.
Subscribe To Our Newsletter & Stay Updated
